Pub. Date : 2017 May 9
PMID : 28492898
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Selumetinib Plus Docetaxel Compared With Docetaxel Alone and Progression-Free Survival in Patients With KRAS-Mutant Advanced Non-Small Cell Lung Cancer: The SELECT-1 Randomized Clinical Trial. | AZD 6244 | KRAS proto-oncogene, GTPase | Homo sapiens |
2 | Objective: To compare efficacy of the mitogen-activated protein kinase kinase (MEK) inhibitor selumetinib + docetaxel with docetaxel alone as a second-line therapy for advanced KRAS-mutant NSCLC. | AZD 6244 | KRAS proto-oncogene, GTPase | Homo sapiens |